12 Recruiting Multiple Myeloma Clinical Trials in Florida
Explore active multiple myeloma research studies enrolling across Florida. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Multiple Myeloma Studies in Florida
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Daratumumab
📍 University of Miami Sylvester Cancer Center — Miami, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
📍 Jupiter Medical Center/Anderson Family Cancer Institute — Jupiter, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
IMMUNOPLANT for Newly Diagnosed Multiple Myeloma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
📍 University of Miami Hospitals — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
📍 Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center — Coral Gables, Florida
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
📍 Sylvester Comprehensive Cancer Center — Miami, Florida
View Study & Checklist ➔